NLRP3 and Parkinson disease: MIF (macrophage migration inhibitory factor) reduces the expression of NLRP3 inflammasome and inflammatory factors induced by MPP+ (1-methyl-4-phenylpyridinium) in microglia, reducing DA neuronal damage and exerting protective effects against neuroinflammation induced by Parkinson’s disease [104].